Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_assertion type Assertion NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_head.
- NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_assertion description "[Multivariate analysis revealed an inferior overall survival and a higher AML transformation rate for the genotype ZRSR2(mut)/TET2(wt) (overall survival: hazard ratio = 3.3; 95% CI, 1.4-7.7; P = .006; AML transformation: hazard ratio = 3.6; 95% CI, 2-4.2; P = .026).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_provenance.
- NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_assertion evidence source_evidence_literature NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_provenance.
- NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_assertion SIO_000772 22343920 NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_provenance.
- NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_assertion wasDerivedFrom befree-20150227 NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_provenance.
- NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_assertion wasGeneratedBy ECO_0000203 NP793229.RAsVYolEODPQ5F9mqmBGF2MYSlPJKjNy2IuUIGpGHn3Vc130_provenance.